Bioverativ Company Profile

Aggregated data from the web about Bioverativ

Company Name	Bioverativ
Website	https://en.wikipedia.org
Snippet	Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta (acquired by Shire Plc in 2016), Pfizer and Novo Nordisk. The company traded on the NASDAQ exchange under the ticker symbol BIVV until Sanofi completed its acquisition on March 8, 2018.
Type	Subsidiary
Parent	Sanofi
Founded	2016
Website	sanofi.com
Industry	Biotechnology
Products	Alprolix, Eloctate
Key people	John G. Cox (CEO)[1]
Headquarters	Waltham
Number of employees	400[2]

Bioverativ is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.